This study examines the association between contingent liability disclosure (CLD) and stock price synchronicity in India, assessing whether CLD facilitates the incorporation of firm-specific information into stock prices. Using panel data comprising 5,483 firm-year observations from 2006–2023, synchronicity is estimated using the Capital Asset Pricing Model (CAPM) and the Fama–French four-factor and six-factor models. Higher CLD is associated with lower synchronicity across model specifications, consistent with greater incorporation of firm-specific information into stock prices. Financial contingencies exhibit the most consistently significant negative association, followed by operational contingencies, while evidence for transaction-related contingencies is less consistent. The association also varies across market environments: it is weaker among passive-fund stocks but remains evident among stocks with derivatives trading and across different levels of intraday trading activity. The study contributes to the corporate disclosure and capital-market literature by distinguishing among categories of contingent liabilities and providing evidence from an emerging market with evolving disclosure regulations and concentrated ownership. The findings reflect disclosure-adjusted contingent liability exposure rather than disclosure quality alone.
No takes yet. Share an insight, caveat, or question.
Srikanth Potharla (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: